Designed by Katemangostar / Freepik
As scientific breakthroughs in healthcare advance, our ability to discover and diagnose diseases earlier has renewed the need for paediatric research. However, there has been a growing tension between the need to license medication, strict regulations, and the recognised unprofitability of conducting trials in the paediatric population.
A major consideration in paediatric trials involves balancing the rights, safety, and well-being of children while meeting financial requirements to enable the production of safe, licensed medication. Perceived challenges in striking this balance may be a deterrent for some pharmaceutical companies.
Some of the key challenges include a lack of paediatric trials, leading to fewer licensed medications for children, misconceptions and mistrust participants may have in research, which may hinder participation in clinical trials, and how the industry may influence paediatric research through community education, with a hope that children will not be left behind as healthcare research continues to progress.
|